Mounjaro Shortage 2024 Update: Understanding the Causes and Managing the Impact
Mounjaro (tirzepatide) is a key drug for type 2 diabetes. It also causes major weight loss. In 2024, major supply chain disruptions caused a shortage of this critical drug. This shortage has posed significant challenges for both patients and healthcare providers. It’s vital to know the causes of the shortage, its effects, and solutions. This …
Read More “Mounjaro Shortage 2024 Update: Understanding the Causes and Managing the Impact”